
-
UFC star McGregor suspended 18 months over missed drug tests
-
Trump talks up Canada trade deal chances with 'world-class' Carney
-
Ecuador president unharmed after apparent gun attack on motorcade
-
Lyon exact revenge on Arsenal, Barca thrash Bayern in women's Champions League
-
Trump says 'real chance' to end Gaza war as Israel marks attacks anniversary
-
Gerrard brands failed England generation 'egotistical losers'
-
NFL fines Cowboys owner Jones $250,000 over gesture to fans
-
Bengals sign veteran quarterback Flacco after Burrow injury
-
New prime minister inspires little hope in protest-hit Madagascar
-
Is Trump planning something big against Venezuela's Maduro?
-
EU wants to crack down on 'conversion therapy'
-
French sex offender Pelicot says man who abused ex-wife knew she was asleep
-
Trump says 'real chance' to end Gaza war as Israel marks Oct 7 anniversary
-
UK prosecutors to appeal dropped 'terrorism' case against Kneecap rapper
-
Spain, Inter Miami star Alba retiring at end of season
-
EU targets foreign steel to rescue struggling sector
-
Djokovic vanquishes exhaustion to push through to Shanghai quarters
-
Trump talks up Canada deal chances with visiting PM
-
Knight rides her luck as England survive Bangladesh scare
-
Pro-Gaza protests flare in UK on anniversary of Hamas attack
-
Top rugby unions warn players against joining rebel R360 competition
-
Outcast Willis 'not overthinking' England absence despite Top 14 clean sweep
-
Trump says 'real chance' of Gaza peace deal
-
Macron urged to quit to end France political crisis
-
No.1 Scheffler seeks three-peat at World Challenge
-
Canadian PM visits Trump in bid to ease tariffs
-
Stocks falter, gold shines as traders weigh political turmoil
-
Senators accuse US attorney general of politicizing justice
-
LeBron's 'decision of all decisions' a PR stunt
-
Observing quantum weirdness in our world: Nobel physics explained
-
WTO hikes 2025 trade growth outlook but tariffs to bite in 2026
-
US Supreme Court hears challenge to 'conversion therapy' ban for minors
-
Italy's Gattuso expresses Gaza heartache ahead of World Cup qualifier with Israel
-
EU targets foreign steel to shield struggling sector
-
Djokovic vanquishes exhaustion to push through to Shanghai quarterfinals
-
Stocks, gold rise as investors weigh AI boom, political turmoil
-
Swiatek coasts through Wuhan debut while heat wilts players
-
Denmark's Rune calls for heat rule at Shanghai Masters
-
Japanese football official sentenced for viewing child sexual abuse images
-
Stocks, gold steady amid political upheaval
-
'Veggie burgers' face grilling in EU parliament
-
Trio wins physics Nobel for quantum mechanical tunnelling
-
Two years after Hamas attack, Israelis mourn at Nova massacre site
-
German factory orders drop in new blow to Merz
-
Man City star Stones considered retiring after injury woes
-
Kane could extend Bayern stay as interest in Premier League cools
-
Renewables overtake coal but growth slows: reports
-
OpenAI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Extreme rains hit India's premier Darjeeling tea estates
-
Raducanu retires from opening match in Wuhan heat with dizziness

Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Wednesday, August 13, 2025 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through August 27, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13754961.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
L.Harper--AMWN